CRVS
Price
$12.56
Change
+$0.65 (+5.46%)
Updated
Jun 22 closing price
Capitalization
1.06B
49 days until earnings call
Intraday BUY SELL Signals
MAIA
Price
$1.38
Change
-$0.02 (-1.43%)
Updated
Jun 22 closing price
Capitalization
83.91M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRVS vs MAIA

CRVS vs MAIA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRVS vs. MAIA commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a Buy and MAIA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (CRVS: $12.57 vs. MAIA: $1.38)
Brand notoriety: CRVS and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 86% vs. MAIA: 57%
Market capitalization -- CRVS: $1.06B vs. MAIA: $83.91M
CRVS [@Biotechnology] is valued at $1.06B. MAIA’s [@Biotechnology] market capitalization is $83.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 0 FA rating(s) are green whileMAIA’s FA Score has 1 green FA rating(s).

  • CRVS’s FA Score: 0 green, 5 red.
  • MAIA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRVS and MAIA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 4 TA indicator(s) are bullish while MAIA’s TA Score has 5 bullish TA indicator(s).

  • CRVS’s TA Score: 4 bullish, 4 bearish.
  • MAIA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MAIA is a better buy in the short-term than CRVS.

Price Growth

CRVS (@Biotechnology) experienced а +5.63% price change this week, while MAIA (@Biotechnology) price change was +1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.46%. For the same industry, the average monthly price growth was +1.63%, and the average quarterly price growth was +2204.18%.

Reported Earning Dates

CRVS is expected to report earnings on Aug 11, 2026.

MAIA is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+4.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVS($1.06B) has a higher market cap than MAIA($83.9M). CRVS YTD gains are higher at: 63.247 vs. MAIA (-9.804). MAIA has higher annual earnings (EBITDA): -23.71M vs. CRVS (-47.81M). CRVS has more cash in the bank: 237M vs. MAIA (34.4M). CRVS (0) and MAIA (0) have equivalent revenues.
CRVSMAIACRVS / MAIA
Capitalization1.06B83.9M1,260%
EBITDA-47.81M-23.71M202%
Gain YTD63.247-9.804-645%
P/E RatioN/AN/A-
Revenue00-
Total Cash237M34.4M689%
Total Debt834KN/A-
FUNDAMENTALS RATINGS
CRVS: Fundamental Ratings
CRVS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRVSMAIA
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 20 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRVS
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCAUX12.64N/A
N/A
Invesco Income Advantage U.S. Fund A
JBAWX32.38N/A
N/A
JHancock Balanced R6
BRWVX29.54N/A
N/A
MFS Blended Research Growth Eq R6
IESGX27.81N/A
N/A
Sit ESG Growth I
DGAGX35.81N/A
N/A
BNY Mellon Appreciation Investor

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been closely correlated with ACRS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRVS jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
+5.54%
ACRS - CRVS
68%
Closely correlated
+7.56%
RZLT - CRVS
42%
Loosely correlated
+2.59%
AMLX - CRVS
36%
Loosely correlated
+3.89%
OVID - CRVS
35%
Loosely correlated
-0.88%
IBRX - CRVS
35%
Loosely correlated
-2.04%
More

MAIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAIA has been loosely correlated with CRVS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if MAIA jumps, then CRVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
-1.43%
CRVS - MAIA
34%
Loosely correlated
+5.54%
VIR - MAIA
33%
Loosely correlated
+4.48%
ACRS - MAIA
31%
Poorly correlated
+7.56%
CADL - MAIA
30%
Poorly correlated
+10.11%
IBRX - MAIA
29%
Poorly correlated
-2.04%
More